Stereotactic radiotherapy for early stage non-small cell lung cancer

Stereotactic body radiotherapy (SBRT) represents a consolidated treatment option for patients with medically inoperable early stage non-small cell lung cancer (NSCLC). The clinical evidence accumulated in the past decade supports its use as an alternative to surgery with comparable survival outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricardi, Umberto, Badellino, Serena, Filippi, Andrea Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Radiation Oncology 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493429/
https://www.ncbi.nlm.nih.gov/pubmed/26157674
http://dx.doi.org/10.3857/roj.2015.33.2.57

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493429/
https://www.ncbi.nlm.nih.gov/pubmed/26157674
http://dx.doi.org/10.3857/roj.2015.33.2.57

Ejemplares similares